Discover how dextran is redefining hydrogel innovation.
A new study from Aalborg University shows how Pharmacosmos dextran enables the development of safer, photoinitiator-free, and tunable hydrogels — paving the way for breakthroughs in tissue engineering, 3D bioprinting, and drug delivery.


The versatility of dextran continues to unlock new possibilities in biomaterials research.
A recent study from Aalborg University, “A photoinitiator-free UV-curable hydrogel with tunable properties using dextrans modified by adamantane, benzophenone, and β-cyclodextrin”, authored by Ruiqi Jing et al., highlights how dextran from Pharmacosmos can serve as a key building block for biocompatible, tunable, and photoinitiator-free hydrogels — paving the way for safer and smarter materials in biomedical applications.
Traditional hydrogels often rely on photoinitiators to trigger polymer cross-linking under UV light — but these compounds can introduce unwanted toxicity or interfere with biological activity.
The research team at Aalborg University found a way around this challenge.
By chemically modifying dextran with β-cyclodextrin (the “host”) and adamantane or benzophenone (the “guests”), they developed a new UV-curable hydrogel system that can cross-link without added photoinitiators.
The result is a robust, self-healing material whose properties — from viscosity to elasticity — can be finely tuned simply by adjusting the dextran molecular weight and composition
Photoinitiator-free cross-linking: reduces potential toxicity and simplifies formulation.
Excellent biocompatibility: negligible cytotoxicity confirmed in vitro.
Tunable mechanical properties: adjustable stiffness and swelling behavior.
Self-healing performance: retains integrity under mechanical stress, mimicking natural tissue resilience.
These combined features make the system highly attractive for biomedical use — particularly in fields where material safety, adaptability, and cell compatibility are critical.
One of the most exciting aspects of this study is just how versatile the dextran-based hydrogel can be.
Because the material combines biocompatibility, tunable stiffness, and UV-curable stability, it is particularly promising for tissue engineering — where it can serve as a 3D scaffold supporting cell growth and regeneration.
The hydrogel also supports cell encapsulation, suggesting potential in 3D bioprinting applications for soft tissue construction.
Moreover, the presence of β-cyclodextrin, a well-known molecular carrier, opens opportunities for controlled drug delivery and other biomedical systems.
This research underscores the versatility of dextran as a functional polymer for biomedical innovation. Its adaptability in hydrogel design, combined with excellent biocompatibility, positions dextran as a cornerstone material in the advancement of regenerative medicine and biofabrication technologies.

Tina Marwood is an International Carbohydrate & Cell Media Scientist at Pharmacosmos with more than 20 years of experience in molecular biology, chemistry, and bioprocess development. She specializes in carbohydrate-based biomaterials and cell media innovation. Tina holds an MSc and PhD in Molecular Biology and Chemistry from Roskilde University.
Contact us